In an era of high-definition imaging, the "incidental finding" has become a daily challenge for the primary care physician. From the indeterminate liver lesion to the asymptomatic pancreatic cyst, the line between "benign" and "borderline" is thinner than ever.
Join us for a high-impact session on navigating the HPB decision tree. This talk moves beyond generic guidelines, offering a bespoke approach to fatty liver screening -using advanced biomarkers and imaging - and a masterclass on interpreting tumor markers without the anxiety.
Finally, catch a glimpse into the future of surgical precision, from the dexterity of robotic resections to the frontier of cancer vaccines.
Learn when to worry, when to wait, and how precision medicine is rewriting the HPB playbook.
Date: 17 Apr 2026 (Fri)
Time: 1:00 PM – 2:00 PM (registration starts at 12.30pm)
Venue: Virtual
CME credits issued: CME credit pending
Topics and Speakers:
